Brief: Moberg Pharma: U.S. Patent Granted For BUPI
May 2 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* U.S. PATENT GRANTED FOR BUPI
* MOBERG PHARMA ESTIMATES THAT PRODUCT HAS A SALES POTENTIAL
AMOUNTING TO USD 100-200 MILLION ANNUALLY
Source text for Eikon: ID:nWkr9b25Nq
Further company coverage: MBPH.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))